New hope for toddlers with bladder nerve damage: mirabegron trial launches
NCT ID NCT05621616
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a liquid medicine called mirabegron in children aged 6 months to 3 years who have bladder problems due to nerve damage (neurogenic detrusor overactivity). The goal is to see if the medicine helps the bladder hold more urine safely, reducing leaks and pressure. Children take the medicine once daily for up to a year, starting with a low dose that may be increased. The study involves about 7 participants who already use a catheter to empty their bladder.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DETRUSOR SPHINCTER DYSSYNERGIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Site PH63001
Quezon, Philippines
-
Site PH63002
Quezon City, Philippines
-
Site PL48001
Gdansk, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill aims to improve bladder function in children with spinal conditions
- Spinal zaps may boost leg strength in kids with spina bifida
- Womb surgery breakthrough: two methods to fix spina bifida before birth
- Timing of breathing tube removal may impact newborn spina bifida recovery
- Fetal surgery immune mystery: why do some babies arrive too early?
- Which enema works best for spina bifida? new study seeks answers